ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $290,000 | +37.4% | 1,683 | 0.0% | 0.00% | – |
| Q2 2021 | $211,000 | -7.5% | 1,683 | 0.0% | 0.00% | – |
| Q1 2021 | $228,000 | -17.1% | 1,683 | -21.8% | 0.00% | – |
| Q4 2020 | $275,000 | +95.0% | 2,151 | +71.9% | 0.00% | – |
| Q3 2020 | $141,000 | -17.1% | 1,251 | -29.9% | 0.00% | – |
| Q2 2020 | $170,000 | +102.4% | 1,785 | +91.7% | 0.00% | – |
| Q1 2020 | $84,000 | -16.8% | 931 | -51.0% | 0.00% | – |
| Q4 2019 | $101,000 | +1583.3% | 1,900 | +1800.0% | 0.00% | – |
| Q3 2018 | $6,000 | -84.6% | 100 | -87.5% | 0.00% | – |
| Q2 2018 | $39,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |